MDA-MB-231, a triple negative breast cancer cell line, has mesenchymal-like phenotype and can undergo EMT to be more aggressive during tumor progression [24]; thus, we generated an MDA-MB-231 cell line stably expressing IL-32θ to study the function of IL-32θ in EMT. Here, IL32 is linked to triple-negative breast carcinoma.